Literature DB >> 11789970

Comorbidities and exercise capacity in older patients with intermittent claudication.

L I Katzel1, J D Sorkin, C C Powell, A W Gardner.   

Abstract

Patients with peripheral arterial disease (PAD) and intermittent claudication often have coronary artery disease (CAD) and other comorbid medical problems. There is a paucity of information on the impact of coexistent medical conditions on exercise capacity and functional status in patients with PAD. This study examined the impact of CAD, diabetes, cigarette smoking, prior peripheral surgical revascularization and other medical conditions on claudication pain times and peak oxygen capacity (VO2) during maximal effort treadmill testing in 119 male outpatient volunteers (ankle-brachial index (ABI) of 0.65 +/- 0.2, mean +/- SEM) with a history of Fontaine Stage II PAD. Smoking status was significantly related to ambulatory function. Current smokers had a lower peak VO2 expressed in l/min than either former or never smokers (ANCOVA adjusted for age, p = 0.003). However, after adjustment for body weight, there was only a trend for a difference in peak VO2 between current (13.2 +/- 0.5 ml/kg per min), former (14.2 +/- 0.4 ml/kg per min) and never (15.4 +/- 1.0 ml/kg per min) smokers (ANCOVA, p = 0.10). Current smokers had a shorter time to onset of claudication pain (p = 0.023) and shorter maximal claudication pain times (p = 0.029) than former or never smokers (p = 0.023). The ABI 1 min after cessation of exercise was also lower in smokers compared to former and never smokers (p = 0.018). There were no significant differences in functional performance measures or time to recovery from maximal claudication pain when patients were categorized on the presence or absence of CAD, diabetes, peripheral revascularization, arthritis, hypertension or dyslipidemia. Therefore, smoking adversely affected exercise capacity in these PAD patients, whereas the presence of CAD, diabetes and other medical problems had a relatively minor impact on exercise capacity. In conclusion, the relatively minor impact of comorbid medical conditions on walking ability in patients with PAD reflects the overwhelming limitation in ambulatory function due to the claudication pain.

Entities:  

Mesh:

Year:  2001        PMID: 11789970     DOI: 10.1177/1358836x0100600306

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  8 in total

1.  Diet is associated with ankle-brachial index, inflammation, and ambulation in patients with intermittent claudication.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang; Biyi Shen; Ana I Casanegra; Federico Silva-Palacios; Allen W Knehans
Journal:  J Vasc Surg       Date:  2020-02-28       Impact factor: 4.268

2.  Dietary intake of participants with peripheral artery disease and claudication.

Authors:  Andrew W Gardner; Brianna C Bright; Kelly A Ort; Polly S Montgomery
Journal:  Angiology       Date:  2011-04       Impact factor: 3.619

3.  The effects of smoking status on walking ability and health-related quality of life in patients with peripheral arterial disease.

Authors:  Cynthia Fritschi; Eileen G Collins; Susan O'Connell; Conor McBurney; Jolene Butler; Lonnie Edwards
Journal:  J Cardiovasc Nurs       Date:  2013 Jul-Aug       Impact factor: 2.083

4.  Effect of type 2 diabetes mellitus on exercise intolerance and the physiological responses to exercise in peripheral arterial disease.

Authors:  S Green; C D Askew; P J Walker
Journal:  Diabetologia       Date:  2007-01-20       Impact factor: 10.122

5.  The effect of metabolic syndrome components on exercise performance in patients with intermittent claudication.

Authors:  Andrew W Gardner; Polly S Montgomery
Journal:  J Vasc Surg       Date:  2008-04-14       Impact factor: 4.268

6.  Race and socioeconomic differences associated with endovascular peripheral vascular interventions for newly diagnosed claudication.

Authors:  Caitlin W Hicks; Peiqi Wang; William E Bruhn; Christopher J Abularrage; Ying W Lum; Bruce A Perler; James H Black; Martin A Makary
Journal:  J Vasc Surg       Date:  2020-01-02       Impact factor: 4.268

7.  Patient Characteristics and Comorbidities Influence Walking Distances in Symptomatic Peripheral Arterial Disease: A Large One-Year Physiotherapy Cohort Study.

Authors:  Sarah Dörenkamp; Ilse Mesters; Rob de Bie; Joep Teijink; Gerard van Breukelen
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

8.  INFLUENCE OF DIABETES ON AMBULATION AND INFLAMMATION IN MEN AND WOMEN WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Danuta Sosnowska; Ana I Casanegra; Zoltan Ungvari; Anna Csiszar; Sarah X Zhang; Josh J Wang; William E Sonntag
Journal:  J Clin Transl Endocrinol       Date:  2015-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.